Rchr
J-GLOBAL ID：202301004381851609   Update date: Sep. 22, 2024

Saito Yuki

サイトウ ユウキ | Saito Yuki
Affiliation and department：
Department of Otolaryngology, Head and Neck Surgery University of Tokyo

About Department of Otolaryngology, Head and Neck Surgery University of Tokyo


Job title： Assistant Professor
Research theme for competitive and other funds  (9)：
  • 2021 - 2024 咽頭嗽液のリキッドバイオプシーによる遺伝子パネル検査を用いた中咽頭癌治療最適化
  • 2018 - 2022 Involvement of microbiome in carcinogenesis mechanism of head and neck squamous cell carcinoma
  • 2016 - 2019 Immunoreaction of the head and neck carcinoma.
  • 2016 - 2019 Association of Nerve growth factor and Immune escape for Perineural invasion in Adenoid cystic carcinoma
  • 2016 - 2018 Analysis of circulating tumor DNA of head and neck cancer using dropet digital PCR
Show all
Papers (90)：
  • Yuki Saito, Hidenori Kage, Kenya Kobayashi, Teru Kamogashira, Osamu Fukuoka, Koji Yamamura, Satoshi Yamashita, Masahiko Tanabe, Katsutoshi Oda, Kenji Kondo. Comprehensive genomic profiling from C-CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1. Clinical endocrinology. 2024. 101. 2. 170-179
  • Tomohiro Yoshihira, Motoyuki Umekawa, Yuki Shinya, Hirotaka Hasegawa, Masahiro Shin, Yodai Kikuchi, Yuki Saito, Kenji Kondo, Atsuto Katano, Aya Shinozaki-Ushiku, et al. Role of stereotactic radiosurgery for recurrent skull base acinic cell carcinoma: illustrative case. Journal of neurosurgery. Case lessons. 2024. 7. 11
  • Yuki Saito, Kenya Kobayashi, Osamu Fukuoka, Toshihiko Sakai, Koji Yamamura, Mizuo Ando, Kenji Kondo. Ultra-high combined positive score and high serum albumin are favorable prognostic biomarkers for immune checkpoint inhibitors in head and neck squamous cell carcinoma. Head & neck. 2024. 46. 2. 367-377
  • Koji Yamamura, Yuki Saito, Kenya Kobayashi, Toshiyuki Mukai, Osamu Fukuoka, Ken Akashi, Masafumi Yoshida, Mizuo Ando, Tatsuya Yamasoba. p16 status and high-risk human papilloma virus infection in squamous cell carcinoma of the nasal vestibule. Auris, nasus, larynx. 2023. 50. 6. 942-947
  • Yuki Saito, Hidenori Kage, Kenya Kobayashi, Masafumi Yoshida, Osamu Fukuoka, Koji Yamamura, Toshiyuki Mukai, Katsutoshi Oda, Tatsuya Yamasoba. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas. Head & neck. 2023. 45. 12. 3107-3118
ｍore...
MISC (188)：
  • 齊藤 祐毅, 丹生 健一. Head and Neck Tumor 頭頸部腫瘍 HPV関連頭頸部癌 日本におけるHPV関連頭頸部癌の疾病負担評価. 癌と化学療法. 2024. 51. 7. 704-708
  • 齊藤 祐毅, 松浦 一登, 鬼丸 力也, 別府 武, 三谷 浩樹, 田中 薫, 南 修司郎, 藤井 隆, 平山 裕次, 本間 明宏. 局所進行上顎洞癌に対する超選択的動注と放射線同時併用療法(JCOG1212試験) T4aN0M0の最終解析結果. 頭頸部癌. 2024. 50. 2. 133-133
  • 小林 謙也, 山村 晃司, 齊藤 祐毅, 北山 恵, 川北 大介, 吉本 世一, 丹生 健一. 頭頸部領域の肉腫における組織型別の臨床的特徴 頭頸部悪性腫瘍全国登録からの報告. 頭頸部癌. 2024. 50. 2. 145-145
  • 篠崎 剛, 樽谷 貴之, 岡本 伊作, 小村 豪, 牧野 琢丸, 遠藤 一平, 櫛橋 幸民, 大峡 慎一, 和佐野 浩一郎, 齊藤 祐毅, et al. 上咽頭癌再発遺残に対するアルミノックス療法 多施設観察研究. 頭頸部癌. 2024. 50. 2. 189-189
  • 齊藤 祐毅. 【頭頸部がん診療のControversy】HPV関連中咽頭がんに対する治療 どっちを選ぶ? TORS vs CRT 化学放射線療法(CRT). 耳鼻咽喉科・頭頸部外科. 2024. 96. 4. 358-360
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM